Skip to main content
All lobbying filings

Abbott Laboratories

Abbott Laboratories filed a Q2 report for Abbott Laboratories on July 20, 2026.

Lobbying for Abbott Laboratories

As filed: ABBOTT LABORATORIES for ABBOTT LABORATORIES.

All filings by Abbott Laboratories · Everything Abbott Laboratories has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$1,150,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • ASHLI DOUGLAS New on this filing
    Previously held: (Employee of affiliated org. Exact Sciences Corporation.)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 8

S.2003 The Strengthening Benefit Plans Act of 2025.

Proposals related to The United States-Mexico-Canada Agreement (USMCA). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.

Proposals related to data privacy/data collection, usage and retention.

S.2426/H.R.3164 Equitable Community Access to Pharmacist Services Act. S.4118/H.R.7966 The Hospice Care Accountability, Reform and Enforcement Act of 2026. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to digital health technologies and innovations. Proposals related to medical device cybersecurity. Proposals related to colorectal cancer screening. Proposals to support updates to the Veteran colorectal cancer screening directive. Proposals regarding the creation of quality measures for colorectal cancer screening.

Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the National Coverage Determination for colorectal cancer screening. Proposals related to the competitive bidding process. Proposals related to The RAPID (Regulatory Alignment for Predictable and Immediate Device) coverage pathway initiative for eligible Breakthrough Medical Devices.

Proposals related to U.S. global health programs and pandemic preparedness.

Proposals related to third party litigation reform.

S.3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R.2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. H.R.9817 Toxic Free Food Act of 2024. H.R.4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to infant formula ingredients. Proposals related to access to infant formula. Proposals related to oral nutrition supplements usage in hospital care settings.

 Bills named in this filing 9
  • S. 2003
    Strengthening Benefit Plans Act of 2025
  • S. 2426
    Equitable Community Access to Pharmacist Services Act
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • S. 4118
    Hospice CARE Act of 2026
  • H.R. 7966
    Hospice CARE Act of 2026
  • S. 3387
    Ensuring Safe and Toxic-Free Foods Act of 2023
  • H.R. 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
  • H.R. 9817
    Toxic Free Food Act of 2024
  • H.R. 4958
    GRAS Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem